SHAPERON INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,568 KRW | -0.51% |
|
-12.84% | -58.30% |
| 03-18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
| 2022 | Shaperon Inc. has completed an IPO in the amount of KRW 13.735 billion. | CI |
| Sales 2022 | 2B 1.46M 116M | Sales 2023 | 215M 158K 12.43M | Capitalization | 86.75B 63.5M 5.01B |
|---|---|---|---|---|---|
| Net income 2022 | -10.67B -7.81M -616M | Net income 2023 | -12.4B -9.08M -716M | EV / Sales 2022 | 64 x |
| Net cash position 2022 | 31.58B 23.12M 1.82B | Net cash position 2023 | 19.54B 14.3M 1.13B | EV / Sales 2023 | 312 x |
| P/E ratio 2022 |
-13.3
x | P/E ratio 2023 |
-6.96
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.35% |
More Fundamentals
* Assessed data
| 1 day | -0.51% | ||
| 1 week | -12.84% | ||
| Current month | -20.69% | ||
| 1 month | -25.69% | ||
| 3 months | -47.99% | ||
| 6 months | -54.42% | ||
| Current year | -58.30% |
1 week
1 540.00
1 736.00
1 month
1 540.002 180.00
Current year
1 540.004 015.00
1 year
1 540.006 420.00
3 years
1 540.0011 600.00
5 years
1 540.0011 600.00
10 years
1 540.0011 600.00
| Managers | Title | Age | Since |
|---|---|---|---|
Seung-Yong Sung
CEO | Chief Executive Officer | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/05/24 | 1,568 | -0.51% | 144,283 |
| 22/05/24 | 1,576 | -1.44% | 146,573 |
| 21/05/24 | 1,599 | -1.90% | 249,231 |
| 20/05/24 | 1,630 | -1.51% | 236,574 |
| 17/05/24 | 1,655 | -4.67% | 501,827 |
End-of-day quote Korea S.E., May 22, 2024
More quotes
Shaperon Inc is a Korea-based company mainly engaged in the biopharmaceutical business. The Company is engaged in the research, development (R&D), manufacture and sale of pneumonia therapy, alzheimer's disease therapy and atopic therapy as well as other medicines.
Calendar
11/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -58.30% | 26.62M | |
| +10.79% | 115B | |
| +11.65% | 106B | |
| -6.20% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -13.41% | 17.56B | |
| -40.50% | 17.32B | |
| +6.64% | 14.03B | |
| +31.84% | 12.13B |
- Stock Market
- Equities
- A378800 Stock
